QTUM vs. QNTM

Last updated Apr 2, 2026

Compare and contrast key facts about Defiance Quantum ETF (QTUM) and Quantum BioPharma Ltd (QNTM).

QTUM is a passively managed fund by Defiance that tracks the performance of the BlueStar Machine Learning and Quantum Computing Index. It was launched on Sep 5, 2018.

Performance

QTUM vs. QNTM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Defiance Quantum ETF (QTUM) and Quantum BioPharma Ltd (QNTM). The values are adjusted to include any dividend payments, if applicable.

QTUM vs. QNTM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
QTUM Defiance Quantum ETF	-0.14%	36.65%	50.54%	39.86%	-28.80%	35.18%	42.05%	47.99%	-19.02%
QNTM Quantum BioPharma Ltd	-39.59%	98.37%	-93.84%	16.67%	-22.71%	-34.62%	-71.27%	-87.38%	-14.40%

Returns By Period

In the year-to-date period, QTUM achieves a -0.14% return, which is significantly higher than QNTM's -39.59% return.

QTUM

• 1D: 1.85%
• 1M: -6.11%
• YTD: -0.14%
• 6M: 3.08%
• 1Y: 47.58%
• 3Y*: 34.18%
• 5Y*: 18.84%
• 10Y*: —

QNTM

• 1D: -8.70%
• 1M: 22.50%
• YTD: -39.59%
• 6M: -73.32%
• 1Y: -44.81%
• 3Y*: -64.76%
• 5Y*: -48.81%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

QTUM vs. QNTM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QTUM

QTUM Risk / Return Rank: 84
QTUM Sharpe Ratio Rank: 81
QTUM Sortino Ratio Rank: 83
QTUM Omega Ratio Rank: 77
QTUM Calmar Ratio Rank: 91
QTUM Martin Ratio Rank: 88

QNTM

QNTM Risk / Return Rank: 33
QNTM Sharpe Ratio Rank: 27
QNTM Sortino Ratio Rank: 43
QNTM Omega Ratio Rank: 40
QNTM Calmar Ratio Rank: 26
QNTM Martin Ratio Rank: 29

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QTUM vs. QNTM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Defiance Quantum ETF (QTUM) and Quantum BioPharma Ltd (QNTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	QTUM	QNTM	Difference
Sharpe ratio Return per unit of total volatility	1.61	-0.30	+1.90
Sortino ratio Return per unit of downside risk	2.24	0.56	+1.68
Omega ratio Gain probability vs. loss probability	1.30	1.06	+0.24
Calmar ratio Return relative to maximum drawdown	3.16	-0.46	+3.62
Martin ratio Return relative to average drawdown	11.08	-0.71	+11.78
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

QTUM vs. QNTM - Sharpe Ratio Comparison

The current QTUM Sharpe Ratio is 1.61, which is higher than the QNTM Sharpe Ratio of -0.30. The chart below compares the historical Sharpe Ratios of QTUM and QNTM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	QTUM	QNTM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.61	-0.30	+1.90
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.72	-0.37	+1.10
Sharpe Ratio (All Time) Calculated using the full available price history	0.84	-0.36	+1.21

Correlation

The correlation between QTUM and QNTM is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

QTUM vs. QNTM - Dividend Comparison

QTUM's dividend yield for the trailing twelve months is around 1.07%, while QNTM has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018
QTUM Defiance Quantum ETF	1.07%	1.01%	0.61%	0.81%	1.46%	0.48%	0.42%	0.61%	0.21%
QNTM Quantum BioPharma Ltd	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

QTUM vs. QNTM - Drawdown Comparison

The maximum QTUM drawdown since its inception was -38.45%, smaller than the maximum QNTM drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for QTUM and QNTM.

Drawdown Indicators

	QTUM	QNTM	Difference
Max Drawdown Largest peak-to-trough decline	-38.45%	-99.98%	+61.53%
Max Drawdown (1Y) Largest decline over 1 year	-15.26%	-94.00%	+78.74%
Max Drawdown (5Y) Largest decline over 5 years	-38.45%	-98.48%	+60.03%
Current Drawdown Current decline from peak	-9.34%	-99.95%	+90.61%
Average Drawdown Average peak-to-trough decline	-8.40%	-92.06%	+83.66%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.36%	60.55%	-56.19%

Volatility

QTUM vs. QNTM - Volatility Comparison

The current volatility for Defiance Quantum ETF (QTUM) is 9.77%, while Quantum BioPharma Ltd (QNTM) has a volatility of 76.44%. This indicates that QTUM experiences smaller price fluctuations and is considered to be less risky than QNTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	QTUM	QNTM	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.77%	76.44%	-66.67%
Volatility (6M) Calculated over the trailing 6-month period	20.87%	107.92%	-87.05%
Volatility (1Y) Calculated over the trailing 1-year period	29.70%	152.39%	-122.69%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.21%	131.21%	-105.00%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.05%	140.12%	-113.07%